Royalty Pharma plc (NASDAQ:RPRX) Q1 2026 Earnings Call Transcript May 6, 2026
Royalty Pharma plc misses on earnings expectations. Reported EPS is $0.53 EPS, expectations were $1.22.
Operator: Ladies and gentlemen, thank you for standing by. Welcome to the Royalty Pharma First Quarter 2026 Earnings Conference Call. I would like now to turn the conference over to George Grofik, Senior Vice President, Head of Investor Relations and Communications. Please go ahead, sir.
George Grofik: Good...
